These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20197618)

  • 1. [Effect of Ursodeoxycholi acid on liver cirrhosis with hepatitis B].
    Wang X; Shen S; Li N; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):171-5. PubMed ID: 20197618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
    Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
    Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
    Tu XL; Xiao YQ; Chen F
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of therapy with bis-hemisuccinate of ursodeoxycholic acid bisodium salt in patients with chronic hepatitis].
    Pinto A; Parini P; Novelli V; Zagari M; Sangermano A; Orsini M; Salzetta A; Buffarini F; Roda E
    Minerva Med; 1992 Jun; 83(6):359-61. PubMed ID: 1352868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of serum markers in evaluating liver fibrotic changes].
    Hu YY; Liu P; Liu C; Liu CH; Xu LM
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):174-7. PubMed ID: 16556409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
    Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correction of metabolic disturbances in patients with cholestasis].
    Rodonezhskaia EV; Kharchenko NV
    Lik Sprava; 2001; (3):148-9. PubMed ID: 11560006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
    Czaja AJ; Carpenter HA; Lindor KD
    Hepatology; 1999 Dec; 30(6):1381-6. PubMed ID: 10573515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-fibrosis effect of IFN-gamma and IFN-alpha on chronic hepatitis B patients].
    Li XH; Wang CG; Pan XN; Li YX; Zhuang YP
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):243. PubMed ID: 12716531
    [No Abstract]   [Full Text] [Related]  

  • 11. [Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy].
    Wang L; Yan J; Zhang ZH; Wang JB; Du YZ; Li XY; Wang YZ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):585-8. PubMed ID: 15504286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [One year and half treatment with lamivudine in active cirrhosis resulting from chronic hepatitis B].
    Zeng WQ; Guo SH; Zhang DZ; Zhou Z; Ren H; Zhang QH; Wang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):176-8. PubMed ID: 12681069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
    Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
    Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bezafibrate treatment of primary biliary cirrhosis following incomplete response to ursodeoxycholic acid.
    Hazzan R; Tur-Kaspa R
    J Clin Gastroenterol; 2010; 44(5):371-3. PubMed ID: 19881358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model.
    Zeng MD; Lu LG; Mao YM; Qiu DK; Li JQ; Wan MB; Chen CW; Wang JY; Cai X; Gao CF; Zhou XQ
    Hepatology; 2005 Dec; 42(6):1437-45. PubMed ID: 16317674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indigenous and imported low molecular weight heparin in the treatment of chronic hepatitis B and cirrhosis with hepatitis B virus: a prospective randomized controlled clinical study].
    Huang JS; Luo X; Yu JX; Liu W; Chen XW; Xie L; Zhu XY; Chen GY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):408-11. PubMed ID: 17631708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial of heptral in patients with chronic diffuse liver disease with intrahepatic cholestasis syndrome].
    Podymova SD; Nadinskaia MIu
    Klin Med (Mosk); 1998; 76(10):45-8. PubMed ID: 9865018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gamma-glutamyltransferase and alkaline phosphatase in the serum and saliva of patients with hepatic tumors and hepatic cirrhosis].
    Jiménez-Alonso J; Jaimez L; Barrios L; Pérez-Jiménez F; García A; Bejarano R; Ogea JL; Jiménez-Pereperez JA
    Rev Esp Oncol; 1984; 31(2):315-9. PubMed ID: 6152769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.